Mast cells at the host-pathogen interface: Host-protection versus immune evasion in leishmaniasis

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 19-23

  Saha, B ^a   Tonkal, A M D J ^c   Croft, S ^c   Roy, S ^b  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Granuloma; Leishmaniasis; Macrophages; Mast cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 3;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; HOST PARASITE INTERACTION; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOREGULATION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT;

ANIMALS; CELL COUNT; DISEASE SUSCEPTIBILITY; HOST-PARASITE RELATIONS; INTERLEUKIN-3; INTERLEUKIN-4; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; STEM CELLS; T-LYMPHOCYTES;

EID: 3042781953     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02505.x     Document Type: Article

References (25)

1. Ponte_Sucre A, Heise D, Moll H. Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells. Immunology 2001; 104:462-7.
2. Andrade ZA, Reed SG, Roters SB, Sadigursky M. Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol 1984; 114:137-48.
3. Venuprasad K, Banerjee P, Sharma S et al. Human neutrophil expressed CD28 interacts with macrophage expressed B7 to induce IFN-γ and restrict Leishmania growth. J Immunol 2002; 169:920-8.
4. Pearson RD, Uydess IL, Chapman SW, Steigbigel RT. Interaction of human eosinophils with Leishmania donovani. Ann Trop Med Parasitol 1987; 81:735-9.
5. Bogdan C, Rollinghoff M. How do protozoan parasites survive inside macrophages? Parasitol Today 1999; 15:22-8.
6. Galli SJ, Tsai M, Gordon JR et al. Analyzing mast cell development and function using mice carrying mutations at W/c-kit or SI/MGF (SCF) loci. Ann NY Acad Sci 1992; 664:69-88.
7. Wershil BK, Theodos CM, Galli SJ, Titus RJ. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 1994; 152:4563-71.
8. Roberts LJ, Baldwin TM, Curtis JM et al. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J Exp Med 1997; 185:1705-10.
9. V mice. Infect Immun 1993; 61:2242-4.
10. Saha B, Roy HN, Pakrashi A, Chakraborty RN, Roy S. Immunobiological studies in experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible roles in pathogenesis. Eur J Immunol 1991; 21:577-81.
11. + pluripotent progenitor cells. J Immunol 1992; 148:772-7.
12. Ashman RI, Jarboe D, Conrad DH, Huff TF. Mast cell-committed progenitor. In vitro generation of committed progenitors from bone marrow. J Immunol 1991; 146:211-6.
13. Wells E, Mann J. Phosphorylation of a mast cell protein in response to treatment with anti-allergic compounds. Implications for the mode of action of sodium chromoglycate. Biochem Pharmacol 1983; 32:837-42.
14. Awasthi A, Mathur R, Khan A et al. CD40 signaling is impaired in Leishmania major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. J Exp Med 2003; 197:1037-43.
15. Saha B, Saini A, Germond R et al. Susceptibility or resistance to Leishmania infection is dictated by bone marrow derived-macrophages developed under the influence of IL-3 or GMCSF. Eur J Immunol 1999; 29:2319-29.
16. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 1994; 180:2027-37.
17. Bidri M, Vouldoukis I, Mossalayi MD et al. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol 1997; 19:475-83.
18. Boom W, Liebster L, Abbas AK, Titus RG. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun 1990; 58:3863-9.
19. Marone G, Galli SJ, Kitamura Y. Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. Trends Immunol 2002; 23:425-7.
20. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346:274-6.
21. Bogdan C, Moll H, Solbach W, Rollinghoff M. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol 1990; 20:1131-5.
22. Feng ZY, Louis JA, Kindler V et al. Aggravation of experimental cutaneous leishmaniasis in mice by administration of interleukin 3. Eur J Immunol 1988; 18:1245-51.
23. Heinzel FP, Sadick MD, Holaday B et al. Reciprocal expression of IFN-γ or IL-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T subsets. J Exp Med 1989; 169:59-69.
24. Parravicini V, Gadina M, Kovarova M et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002; 3:741-8.
25. MacDonald AJ, Thornton EM, Newlands GF et al. Rat bone marrow-derived mast cells co-cultured with 3T3 fibroblasts in the absence of T-cell derived cytokines require stem cell factor for their survival and maintain their mucosal mast cell-like phenotype. Immunology 1996; 88:375-83.